Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2785)
All Articles published online
|
May 28, 2005 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mao SJ, Hou SX, He R, Zhang LK, Wei DP, Bi YQ, Jin H. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. World J Gastroenterol 2005; 11(20): 3075-3079 [PMID: 15918193 DOI: 10.3748/wjg.v11.i20.3075] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i20/3075.htm |
| Number | Citing Articles |
| 1 |
M. Alagawany, S.S. Elnesr, M.R. Farag. Use of liquorice (Glycyrrhiza glabra) in poultry nutrition: Global impacts on performance, carcass and meat quality. World's Poultry Science Journal 2019; 75(2): 293 doi: 10.1017/S0043933919000059
|
| 2 |
Mahfoozur Rahman, Kainat Alam, Rafida Ilyas, Sarwar Beg. Nanoformulation Strategies for Cancer Treatment. 2021; : 171 doi: 10.1016/B978-0-12-821095-6.00015-X
|
| 3 |
Aihua Lin, Yiming Liu, Yu Huang, Jingbo Sun, Zhifeng Wu, Xian Zhang, Qineng Ping. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. International Journal of Pharmaceutics 2008; 359(1-2): 247 doi: 10.1016/j.ijpharm.2008.03.039
|
| 4 |
Raman Rohilla, Tarun Garg, Jitender Bariwal, Amit K. Goyal, Goutam Rath. Development, optimization and characterization of glycyrrhetinic acid–chitosan nanoparticles of atorvastatin for liver targeting. Drug Delivery 2016; 23(7): 2290 doi: 10.3109/10717544.2014.977460
|
| 5 |
Juan Guan, Wei Chen, Min Yang, Ercan Wu, Jun Qian, Changyou Zhan. Regulation of in vivo delivery of nanomedicines by herbal medicines. Advanced Drug Delivery Reviews 2021; 174: 210 doi: 10.1016/j.addr.2021.04.015
|
| 6 |
Luciano A. Stecanella, Antonio P. R. Bitencourt, Gustavo Richter Vaz, Eride Quarta, José O. C. Silva Júnior, Alessandra Rossi. Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer. Pharmaceutics 2021; 13(11): 1792 doi: 10.3390/pharmaceutics13111792
|
| 7 |
Guangming Gong, Feng Zhi, Kaikai Wang, Xiaolei Tang, Ahu Yuan, Lili Zhao, Dawei Ding, Yiqiao Hu. Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting. Nanotechnology 2011; 22(29): 295603 doi: 10.1088/0957-4484/22/29/295603
|
| 8 |
Deepak Mishra, Nivrati Jain, Vaibhav Rajoriya, Ashish K Jain. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine. Journal of Pharmacy and Pharmacology 2014; 66(8): 1082 doi: 10.1111/jphp.12235
|
| 9 |
Xitong Su, Lei Wu, Mingming Hu, Wenxiang Dong, Meng Xu, Peng Zhang. Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomedicine & Pharmacotherapy 2017; 95: 670 doi: 10.1016/j.biopha.2017.08.123
|
| 10 |
Yuxiang Wang, Wenzhen Wang, Hailu Yao, Jingjing Wang, Fenghe Yang, Yu Zhang, Guanhua Du, Guang Han. Glycyrrhizic Acid-Based Liposome for Tumor-Targeted Delivery of Cantharidin. ACS Applied Nano Materials 2024; 7(1): 1030 doi: 10.1021/acsanm.3c05019
|
| 11 |
Wei Peng, Shumin Cheng, Zhihang Bao, Youjing Wang, Wei Zhou, Junxian Wang, Qingling Yang, Changjie Chen, Wenrui Wang. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021; 137: 111342 doi: 10.1016/j.biopha.2021.111342
|
| 12 |
A.A. D’Souza, P.V. Devarajan . HEPATIC TARGETING – ADDRESSING VITAL THERAPEUTIC NEEDS. INDIAN DRUGS 2015; 52(10): 7 doi: 10.53879/id.52.10.10480
|
| 13 |
AiHua Lin, Jun Chen, YiMing Liu, Shigui Deng, Zhifeng Wu, Yu Huang, QiNeng Ping. Preparation and evaluation ofN-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Drug Development and Industrial Pharmacy 2009; 35(11): 1348 doi: 10.3109/03639040902939197
|
| 14 |
Qin Tian, Wei Wang, XiaoTing He, XiaoCui Zhu, Wei Huang, ChuangNian Zhang, Zhi Yuan, XueSi Chen. Glycyrrhetinic acid-modified nanoparticles for drug delivery: Preparation and characterization. Chinese Science Bulletin 2009; 54(18): 3121 doi: 10.1007/s11434-009-0249-5
|
| 15 |
Ashim Malhotra, Gulnaz Javan, Shivani Soni. Advanced Surfaces for Stem Cell Research. 2016; : 401 doi: 10.1002/9781119242642.ch14
|
| 16 |
L.‐Y. Zha, Z.‐R. Xu, M.‐Q. Wang, L.‐Y. Gu. Chromium nanoparticle exhibits higher absorption efficiency than chromium picolinate and chromium chloride in Caco‐2 cell monolayers. Journal of Animal Physiology and Animal Nutrition 2008; 92(2): 131 doi: 10.1111/j.1439-0396.2007.00718.x
|
| 17 |
|
| 18 |
Zhen Li, Lan Hao, Pei Yuan, Wenjing Hu, Liangke Zhang. Encapsulation of honokiol-loaded nanoparticles in lecithin microbubbles for targeted tumor therapy. RSC Advances 2016; 6(60): 54830 doi: 10.1039/C6RA10047C
|
| 19 |
Piyali Dey, Somasree Ray, Pronobesh Chattopadhyay. Design and Applications of Theranostic Nanomedicines. 2023; : 345 doi: 10.1016/B978-0-323-89953-6.00005-2
|
| 20 |
|
| 21 |
Shi-Hui Liu, Qing-Zhen Wang, Tao Liu, Ru Bai, Man-Man Ma, Qiao-Lin Liu, Hui-Ge Zhou, Jing Liu, Mei Wang. Enhanced Glioblastoma Selectivity of Harmine via the Albumin Carrier. Journal of Biomedical Nanotechnology 2022; 18(4): 1052 doi: 10.1166/jbn.2022.3321
|
| 22 |
Anisha A. D’Souza, Vishvesh M. Joshi, Padma V. Devarajan. Targeted Drug Delivery : Concepts and Design. Advances in Delivery Science and Technology 2015; : 197 doi: 10.1007/978-3-319-11355-5_6
|
| 23 |
Tomoaki Kurosaki, Saki Kawanabe, Yukinobu Kodama, Shintaro Fumoto, Koyo Nishida, Hiroo Nakagawa, Norihide Higuchi, Tadahiro Nakamura, Takashi Kitahara, Hitoshi Sasaki. Hepatic Gene Delivery System Electrostatically Assembled with Glycyrrhizin. Molecular Pharmaceutics 2014; 11(5): 1369 doi: 10.1021/mp400398f
|
| 24 |
Yang Chu, Dan Li, Yi-Fan Luo, Xiao-Jin He, Ming-Yan Jiang. Preparation and In Vitro Evaluation of Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carriers. Molecules 2014; 19(2): 2445 doi: 10.3390/molecules19022445
|
| 25 |
Mingxiang Chang, Meimei Wu, Hanmin Li. Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice. Drug Delivery 2018; 25(1): 1984 doi: 10.1080/10717544.2018.1526227
|
| 26 |
S. Sripriyalakshmi, Pinkybel Jose, Aswathy Ravindran, C. H. Anjali. Recent Trends in Drug Delivery System Using Protein Nanoparticles. Cell Biochemistry and Biophysics 2014; 70(1): 17 doi: 10.1007/s12013-014-9896-5
|
| 27 |
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
|
| 28 |
Islam A. Hassanin, Ahmed O. Elzoghby. Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs. Expert Opinion on Drug Delivery 2020; 17(10): 1437 doi: 10.1080/17425247.2020.1813713
|
| 29 |
Alaa F. Bakr, Ping Shao, Mohamed A. Farag. Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive review. Phytomedicine 2022; 99: 153999 doi: 10.1016/j.phymed.2022.153999
|
| 30 |
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opinion on Drug Delivery 2021; 18(4): 489 doi: 10.1080/17425247.2021.1854223
|
| 31 |
Lili Shi, Cui Tang, Chunhua Yin. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials 2012; 33(30): 7594 doi: 10.1016/j.biomaterials.2012.06.072
|
| 32 |
Nivrati Jain, Vaibhav Rajoriya, Prateek Kumar Jain, Ashish Kumar Jain. Lactosaminated-N-succinyl chitosan nanoparticles for hepatocyte-targeted delivery of acyclovir. Journal of Nanoparticle Research 2014; 16(1) doi: 10.1007/s11051-013-2136-x
|
| 33 |
Wei Huang, Wei Wang, Ping Wang, Qin Tian, Chuangnian Zhang, Chunhong Wang, Zhi Yuan, Min Liu, Haiying Wan, Hua Tang. Glycyrrhetinic acid-modified poly(ethylene glycol)–b-poly(γ-benzyl l-glutamate) micelles for liver targeting therapy. Acta Biomaterialia 2010; 6(10): 3927 doi: 10.1016/j.actbio.2010.04.021
|
| 34 |
Islam A. Hassanin, Mohamed Teleb, Adnan A. Bekhit, Kadria A. Elkhodairy, Sherine N. Khattab, Ahmed O. Elzoghby. Advanced Nanoformulations. 2023; : 341 doi: 10.1016/B978-0-323-85785-7.00022-X
|